GPR120-IN-1 is primarily used in research to study the role of GPR120 receptors in metabolic and inflammatory processes. It acts as an inhibitor, helping scientists understand how blocking GPR120 affects insulin sensitivity, glucose metabolism, and inflammation in various diseases like obesity and type 2 diabetes. This compound is valuable in preclinical studies for developing potential therapeutic strategies targeting metabolic disorders. Additionally, it aids in exploring the relationship between GPR120 signaling and conditions such as fatty liver disease and cardiovascular complications.